Pulmonary Hypertension Accreditation
Fewer than 50 hospitals in the U.S. have earned accreditation from the Pulmonary Hypertension Association as a Center of Comprehensive Care. Only the highest quality, most comprehensive centers receive this accreditation. Henry Ford is one of only two hospitals in Michigan to receive this distinction. The rigorous accreditation process ensures that we meet the highest standards of care. Our treatments are based on scientific evidence, and we continually research new options to improve the overall health and wellbeing of patients suffering from this condition.
The Clinical Trials Network for the Prevention and Early Treatment of Acute Lung Injury is a network of 12 Clinical Centers (CC) and 1 Clinical Coordinating Center (CCC) funded by the National Heart, Lung, and Blood Institute (NHLBI) to develop and conduct randomized controlled clinical trials to prevent or treat, and/or improve the outcome of patients who have, or who are at risk for, Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Studies performed here were:
- ROSE: Reevaluation of Systemic Early neuromuscular blockade
- VIOLET: Vitamin D to Improve Outcomes by Leveraging Early Treatment
Bronchial Thermoplasty with Asthmatx, a Boston Scientific Company.
Bronchial Thermoplasty (BT) is an outpatient procedure for people with severe asthma, proven to reduce asthma attacks for at least 5 years. It uses thermal energy to reduce the muscle associated with airway constriction in asthma patients and is the first FDA-approved non-drug procedure for the treatment of severe asthma
Auris Monarch™ Platform - BENEFIT study
The Monarch™ Platform featuring robotic-assisted bronchoscopy was introduced in 2018 to help physicians reach hard-to-reach nodules for biopsy. The Monarch technology helps physicians map out a pathway to the nodule so that they never lose sight of the path ahead. The bronchoscope and sheath telescoping design provide stability and control. The sheath can be articulated up to 130 degrees in any direction to create a stable base to advance the small bronchoscope. Once advanced beyond the sheath, the bronchoscope provides an additional 180 degrees of flexion in any direction
Ion™ Endoluminal System – PRECISE study
A robotic-assisted endoluminal platform for minimally invasive peripheral lung biopsy. Ion’s ultra-thin robotic catheter and advanced maneuverability allow navigation far into the peripheral lung. The 3.5 mm outer-diameter catheter with a 2.0 mm working channel can pass through small and difficult-to-navigate airways—around tight bends to reach all 18 segments of the lung. The catheter moves 180° in all directions and enables fine adjustment for precise biopsy.